You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | -9.0% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -4.9 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 0.4 |
Price / Book value | 20.5 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 23.7% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-06-30 | n/a | -1.68 | -2.50p | -8.7 | 0.0 | n/a | n/a | 0.0% |
2020-06-30 | 0.05 | -1.12 | -1.50p | -17.5 | 0.0 | n/a | n/a | 0.0% |
2021-06-30 | n/a | -1.72 | -2.30p | -125.0 | 0.0 | n/a | n/a | 0.0% |
2022-06-30 | n/a | 2.58 | -3.20p | -63.3 | 0.0 | n/a | n/a | 0.0% |
2023-06-30 | n/a | -4.03 | -4.70p | -26.6 | 0.0 | n/a | n/a | 0.0% |
Sareum allowed European patent for primary kinase inhibitor asset Sharecast News | 15 Mar |
---|---|
Sareum reports positive progress in psoriasis programme Sharecast News | 15 Feb |
Sareum shares jump on cancer drug licensing deal Sharecast News | 02 Jan |
Final Issue of RiverFort Subscription Shares | 23-Apr-24 07:01 |
---|---|
Issue of RiverFort Subscription Shares | 19-Apr-24 11:35 |
Issue of RiverFort Subscription Shares | 15-Apr-24 20:44 |
Issue of RiverFort Subscription Shares | 09-Apr-24 22:46 |
Completion of Equity Fundraise | 04-Apr-24 23:51 |